Abstract
Rapid advances in nucleic acid nanotechnology have transformed our view of nucleic acids from key biological components to versatile building materials. By programming the specific molecular forces including Watson-Crick base pairing, hydrophobic interactions, and protein binding, the physicochemical properties (e.g., size, shape, sequence, valency) of nucleic acid nanostructures can be engineered to control their interactions with specific biological components. Importantly, nucleic acids are intrinsic immune regulators that can initiate or suppress immune activation. In this brief review, we highlight recent advances in the design of nucleic acid-based nanostructures in modulating the immune system, focusing on the nanoparticle transport in the lymphatic system, interactions between signaling molecules and immune cells, and nanoparticle strategies to enhance, evade, deviate, or suppress the immune activation. Nucleic acid nanotechnology provides important avenues and opportunities for future immunotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.